相关实验视频

Updated: Jul 2, 2025

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

复发缓解多发性硬化症恶性进展中的预测因素和治疗挑战

Masoud Ghiasian¹, Rashed Bawand², Sulmaz Jabarzadeh³

¹Department of Neuroimmunology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

|February 29, 2024

概括

恶性复发性复发性硬化症 (RRMS) 的预测因素包括发病时的年龄和男性性别. 目前的治疗方法对于恶性RRMS是不够的,需要新的治疗策略以获得更好的结果.

科学领域:

神经学神经学
免疫学免疫学免疫学
医学研究医学研究

背景情况:

复发性转移性多发性硬化症 (RRMS) 呈现出疾病严重程度的范围.
区分良性和恶性形式的RRMS对于有效治疗至关重要.
恶性病变进展的预测因素仍然是积极调查的领域.

研究的目的:

为了确定RRMS恶性进展的预后因素.
为了比较良性和恶性RRMS表型之间的治疗反应.
评估不同形式的RRMS当前治疗策略的疗效.

主要方法:

一项队列研究涉及254名RRMS患者,分类为良性 (≥10年疾病发作,EDSS ≤1) 或恶性 (≤5年疾病发作,EDSS ≥6).
收集和统计分析患者数据,包括人口统计,病史,治疗和MRI扫描.
良性和恶性RRMS组之间的临床和放射性特征的比较.

主要成果:

恶性RRMS患者的发病平均年龄较高 (32.00 ± 7.96 vs 25.70 ± 17.19,P < 0.001),而且男性发病率更高 (40% vs 18.4%,P = 0.014).
恶性RRMS在五年内出现了更多的复发 (中位数为4比2,P<0.001) 和住院 (中位数为2比1,P=0.006).
核磁共振扫描显示,在下/带区域的斑块负担较高,在恶性RRMS中出现更多的黑洞病变.

结论:

发病时的年龄较大,男性性别,复发增加,多焦点发作和特定的MRI发现预测恶性RRMS.
目前的疾病修饰疗法 (DMT) 的升级策略对于恶性RRMS是不够的.
RRMS是一种异质的疾病,需要超越当前升级协议的量身定制的治疗方法.

关键词:

良性的MSMS是良性的改变疾病的疗法.升级升级的升级情况恶性多发性硬化症 (MS)预测预后预测预测复发性转移性多发性硬化症 (RRMS)

更多相关视频

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

相关概念视频

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...